Silexion Therapeutics Ltd. (SLXN) tiene un P/E histórico negativo de -0.3, lo que significa que la empresa actualmente no es rentable en base a los últimos doce meses (TTM). El rendimiento de ganancias histórico es -349.53%.
Criterios demostrados por esta página:
Puntuación General SharesGrow: 73/100 con 4/7 criterios aprobados.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendimiento por Dividendo |
|---|---|---|---|---|---|
| 2020 | -22,184.7 | 0.00 | -25,560.83 | 0.00 | - |
| 2021 | -5,753.4 | -20.20 | 37.81 | 0.00 | - |
| 2022 | -1,369.7 | 7.77 | -412.90 | 0.00 | - |
| 2023 | -59.5 | 0.00 | -19.00 | 0.00 | - |
| 2024 | -11.4 | 0.28 | -47.15 | 0.00 | - |
| 2025 | -0.2 | 0.00 | 0.98 | 0.00 | - |
| Year | EPS (Diluido) | Ingresos | Ingreso Neto | Margen Neto |
|---|---|---|---|---|
| 2020 | $-0.12 | $0.00 | $-196K | - |
| 2021 | $-0.46 | $0.00 | $-755K | - |
| 2022 | $-0.39 | $0.00 | $-3.22M | - |
| 2023 | $-0.61 | $0.00 | $-4.94M | - |
| 2024 | $2.03 | $0.00 | $16.51M | - |
| 2025 | $-8.96 | $0.00 | $-11.91M | - |
| Year | EPS (Prom.) | Rango EPS | Ingresos (Prom.) | Rango de Ingresos | Analistas |
|---|---|---|---|---|---|
| 2026 | $-4.12 | $-4.12 – $-4.12 | $0.00 | $0.00 – $0.00 | 1 |
| 2027 | $-2.23 | $-2.72 – $-1.74 | $0.00 | $0.00 – $0.00 | 2 |
| 2028 | $-2.67 | $-2.67 – $-2.67 | $0.00 | $0.00 – $0.00 | 1 |
| 2029 | $-2.54 | $-2.54 – $-2.54 | $0.00 | $0.00 – $0.00 | 1 |
| 2030 | $-0.39 | $-0.39 – $-0.39 | $34.99M | $34.99M – $34.99M | 1 |
